Effect of hemostasis modifiers of the activity of VP 16 213 on Lewis lung carcinoma.
D000818:Animals; D001241:Aspirin / Q000494:pharmacology*; D005047:Etoposide / Q000627:therapeutic use*; D006487:Hemostasis / Q000187:drug effects*; D006493:Heparin / Q000494:pharmacology*; D008175:Lung Neoplasms / Q000188:drug therapy*; D051379:Mice; D008810:Mice, Inbred C57BL; D009362:Neoplasm Metastasis / Q000517:prevention & control*; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D011034:Podophyllotoxin / Q000031:analogs & derivatives*; D014184:Transplantation, Homologous
D005047:Etoposide; D006493:Heparin; D011034:Podophyllotoxin; D001241:Aspirin